Premium
Symposium i‐2. pathophysiology and treatment of pressure ulcer
Moderated by Hiroyuki Kuwano: Administration of Basic Fibroblast Growth Factor (bFGF) for Intractable Rectovesical Fistula — a Case Report
Author(s) -
Onozato Ryoichi,
Yamaguchi Satoru,
Asao Takayuki,
Kobayashi Tsutomu,
Tsutsumi Soichi,
Kuwano Hiroyuki
Publication year - 2005
Publication title -
wound repair and regeneration
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.847
H-Index - 109
eISSN - 1524-475X
pISSN - 1067-1927
DOI - 10.1111/j.1067-1927.2005.130116ai.x
Subject(s) - medicine , fistula , surgery , abscess , basic fibroblast growth factor , growth factor , receptor
Case: 62‐year‐old female. Drainage of abscess and hysterectomy were performed for pelvic peritonitis. But stool‐like exudates was observed at postoperative 2 days. Transverse colostomy and drainage of the abscess were performed. Transvaginal closure of the vaginal stump was performed for rectovaginal fistula. After a while, intractable rectovesical fistula was newly observed. Clinical course: Because patient was contracted articular rheumatism, she wanted to avoid operation. Under sufficient informed consent, we started the treatment of injection with bFGF via the drainage tube to rectovesical fistula (50 μg/day). Narrowness of the fistula was checked by fistulography, and decrease of eduction of stool like exudates was observed. The fistula was closed after 2.5 months from beginning of the treatment. Summary: We reported a case that bFGF was available for intractable nontumorous enterogenic fistula.